Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera Signs Agreements In Gene Therapy Research For Congenital Muscular Dystrophy

May 6 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
 SANN.S :
    * SANTHERA SIGNS AGREEMENTS IN GENE THERAPY RESEARCH FOR
CONGENITAL MUSCULAR DYSTROPHY WITH RUTGERS UNIVERSITY
    * SANTHERA GAINS RIGHTS TO INTELLECTUAL PROPERTY DEVELOPED
AT
RUTGERS ON CERTAIN GENE CONSTRUCTS THAT WILL BE FURTHER STUDIED
UNDER A COLLABORATION AGREEMENT.

Source text for Eikon:  ID:nGNE3750S1 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news